Robert E Bristow MD MBA is Professor and Chair of the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine – Medical Center in Orange, California, USA. Professor Bristow’s primary clinical and research interests include the surgical management of advanced-stage gynecologic cancer and the patterns of health care delivery for women with gynecologic cancer. Dr. Bristow is extensively published in the field of ovarian cancer surgical research and he is also a deputy editor of the journal Gynecologic Oncology.Beth Y Karlan MD is Director of the Women’s Cancer Research Institute and the Division of Gynecologic Oncology at Cedars-Sinai Medical Center and Professor of Obstetrics and Gynecology at the David Geffen School of Medicine at the University of California, Los Angeles, California, USA. Professor Karlan’s research interests include molecular biomarker discovery, inherited cancer susceptibility and translational research efforts focused towards innovative treatment strategies for ovarian cancer. She has served as President of the Society of Gynecologic Oncologists and in 2006 was named an American Cancer Society Early Detection Clinical Research Professor. Professor Karlan is the Editor-in-Chief of Gynecologic Oncology.Dennis S Chi MD is Professor and Deputy Chief of the Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. Dr Chi’s primary research interests include the correlation of radiographic evaluation and operative findings in gynecologic malignancies and the utilization of innovative and advanced surgical techniques to improve outcomes for women with early, advanced, or recurrent gynecologic cancers. He is on the editorial board of the journals Journal of Oncology and The Oncologist and has served as the president of the Society of Memorial Gynecologic Oncologists and the Metropolitan Gynecologic Cancer Society.

"...amply meets its goals and fulfills a need for a comprehensive text."- Doody's Review Service"The updates in this fourth edition of a classic textbook amply justify its publication. The book has been thoroughly revised throughout, and several topics have been expanded."- Carol Scott-Conner, MD, PhD, MBA, University of Iowa Hospitals and Clinics

• 1. Historical development of cytoreductive surgery for ovarian cancer and scientific update.2. Epidemiology, staging, and clinical characteristics. 3. Preoperative risk stratification and intraoperative supportive care.4. Instrumentation, retractors, ablative technologies and techniques, set-up and conduct of operation.5. Management of Early-Stage Ovarian Cancer.6. Cytoreductive surgery: Principles and rationale. 7. Predicting Surgical Outcome: Patient Selection for Initial Surgery or Chemotherapy. 8. Cytoreductive Surgery: Pelvis and Radical Oophorectomy. 9. Cytoreductive surgery: Abdominal retroperitoneum and adenopathy. 10. Cytoreductive surgery: Intestinal tract and Omentum.11. Cytoreductive surgery: Right upper abdomen—Diaphragm. 12. Cytoreductive surgery: Right upper abdomen—Liver, gallbladder, and porta hepatis. 13. Cytoreductive surgery: Left upper quadrant. 14. Peritonectomy procedures for ovarian cancer. 15. Regional Therapeutics and Peritonectomy Procedures for Ovarian Cancer. Robert DeBernardo. 16. Secondary cytoreductive surgery. 17. Minimally Invasive Surgery in Ovarian Cancer. 18. Palliative surgery for ovarian cancer. 19. Postoperative management. 20. Quality indicators for ovarian cancer surgery. 21. Ovarian Cancer Surgery in Low Resource Settings: Global Health Program Development Infrastructure.